Sildenafil and aerolized iloprost treatment in two cases with primary pulmonary hypertension

E. Tabakoglu, L. Ozdemir, O. N. Hatipoglu, B. Ozlen, I. Yilmam, G. Altiay, T. Caglar (Edirne, Turkey)

Source: Annual Congress 2005 - Pulmonary hypertension and related pathology
Session: Pulmonary hypertension and related pathology
Session type: Thematic Poster Session
Number: 3380
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Tabakoglu, L. Ozdemir, O. N. Hatipoglu, B. Ozlen, I. Yilmam, G. Altiay, T. Caglar (Edirne, Turkey). Sildenafil and aerolized iloprost treatment in two cases with primary pulmonary hypertension. Eur Respir J 2005; 26: Suppl. 49, 3380

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhaled iloprost plus oral sildenafil in patients with pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 324s
Year: 2001

Long-term treatment of pulmonary hypertension with aerosolized iloprost
Source: Eur Respir J 2001; 17: 8-13
Year: 2001



Intravenous iloprost for treatment failure of aerosolised iloprost in pulmonary arterial hypertension
Source: Eur Respir J 2002; 20: 339-343
Year: 2002



Inhaled iloprost plus oral sildenafil as rescue-treatment in life threatening decompensation of primary pulmonary hypertension (PPHT)
Source: Eur Respir J 2003; 22: Suppl. 45, 429s
Year: 2003

Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension
Source: Eur Respir J 2015; 46: 405-413
Year: 2015



Long-term treatment of pulmonary hypertension with aerosolized iloprost
Source: Eur Respir J 2001; 17: 1334-1335
Year: 2001


Long-term treatment of pulmonary hypertension with aerosolized iloprost
Source: Eur Respir J 2001; 18: 247
Year: 2001


Sildenafil enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 24s
Year: 2002

Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension
Source: Eur Respir J 2007; 29: 469-475
Year: 2007



Sildenafil treatment for portopulmonary hypertension
Source: Eur Respir J 2006; 28: 563-567
Year: 2006



Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2006 Oct 01;28(4):691-694
Year: 2006



Experience with inhaled iloprost and bosentan in portopulmonary hypertension
Source: Eur Respir J 2007; 30: 1096-1102
Year: 2007



Initial combination therapy with epoprostenol and bosentan in severe pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009


Inhaled iloprost for patients with portopulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 462s
Year: 2003

Inhaled iloprost for the treatment of pulmonary hypertension
Source: Eur Respir Rev 2009; 18: 29-34
Year: 2009


Acute effects of Sildenafil and Iloprost in pulmonary hypertension of various aetiology
Source: Eur Respir J 2002; 20: Suppl. 38, 370s
Year: 2002

Inhaled iloprost reverses chronic experimental pulmonary hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 353s
Year: 2005

Inhaled iloprost in HIV-related pulmonary arterial hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 109s
Year: 2004

Consistency of the acute hemodynamic response to inhaled iloprost in pulmonary hypertension patients treated long-term with iloprost aerosol
Source: Eur Respir J 2001; 18: Suppl. 33, 323s
Year: 2001

Inhaled iloprost improves hemodynamics at exercise in primary and secondary precapillary pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 597s
Year: 2002